<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>+G306P323</udiDi>
    <basicUdiDi>++G306P39S</basicUdiDi>
    <tradeName>Kassetten</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CR200</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.834Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P324</udiDi>
    <basicUdiDi>++G306P39S</basicUdiDi>
    <tradeName>Kassetten</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CR20SOHO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.812Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P325</udiDi>
    <basicUdiDi>++G306P39S</basicUdiDi>
    <tradeName>Kassetten</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CR20S</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.791Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P326</udiDi>
    <basicUdiDi>++G306P39S</basicUdiDi>
    <tradeName>Kassetten</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CRP30B</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.767Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P402</udiDi>
    <basicUdiDi>++G306P49U</basicUdiDi>
    <tradeName>CNA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNA 15-2</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.715Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P403</udiDi>
    <basicUdiDi>++G306P49U</basicUdiDi>
    <tradeName>CNA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CNA Quattro</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.688Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P502</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS Mini</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.636Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P503</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS Semi</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.614Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P504</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS ZR</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.596Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P505</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS TF</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.584Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P506</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS Tankumschaltung</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.563Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P507</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AWS ZR</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.540Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P508</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS-01 LN2</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.516Z</lastUpdated>
  </row>
  <row>
    <udiDi>+G306P509</udiDi>
    <basicUdiDi>++G306P59W</basicUdiDi>
    <tradeName>FMCS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Consarctic GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000018983</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V0902</emdnCode>
    <emdnDescription>CLINICAL/THERAPEUTIC APPLICATIONS LIQUID NITROGEN</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FMCS Touch</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T21:03:48.486Z</lastUpdated>
  </row>
</eudamedExport>